Hospital Universitario Vall d´Hebron

Barcelona, Barcelona 08035

4 studies enrolling now · 8 studies all time

What they study most

Breast Cancer, Chronic Myelomonocytic Leukemia, Crohn's Disease, GIST, Gaucher Disease Type 1, Hemophilia A, Hemophilia B, Idiopathic Pulmonary Fibrosis, Interstitial Lung Disease, Leukemia, Myeloid, Acute, Mucopolysaccharidosis II, Myelodysplastic Syndrome With Excess Blasts-2

Studies at this site

• A Gaucher Disease Gene Therapy Trial With FLT201 — Recruiting now
• Study of the Kono-S Anastomosis Versus the Side-to-side Functional End Anastomosis — Recruiting now
• ARTIDIS Nanomechanical Generated Measurements for Early Breast Lesions — Recruiting now
• Clinical Trial to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Tuspetinib (HM43239) in Patients With Relapsed or Refractory Acute Myeloid Leukemia — Recruiting now
• A Study to Determine the Efficacy and Safety of Tividenofusp Alfa (DNL310) vs Idursulfase in Pediatric and Young Adult Participants With Neuronopathic (nMPS II) or Non-Neuronopathic Mucopolysaccharidosis Type II (nnMPS II) — Recruiting now
• Extension Study of Inhaled Treprostinil in Subjects With Fibrotic Lung Disease — Enrolling by invitation
• A Study of Ripretinib vs Sunitinib in Patients With Advanced GIST With Specific KIT Exon Mutations Who Were Previously Treated With Imatinib — Running, not enrolling
• Study of the Efficacy and Safety PF-06741086 in Adult and Teenage Participants With Severe Hemophilia A or Moderately Severe to Severe Hemophilia B — Completed